Table 2 hCD19 CAR-T treatment and outcomes
Variables | No. (n = 19) | % of patients | Numbers of patients | ||
|---|---|---|---|---|---|
Total | CR | Relapse/Death | |||
Grade of CRS | |||||
0 | 1 | 5 | – | – | – |
1 | 15 | 79 | – | – | – |
2 | 2 | 11 | – | – | – |
4 | 1 | 5 | – | – | – |
Neurotoxicity | |||||
No | 17 | 89 | – | – | – |
Grade 1 | 2 | 11 | – | – | – |
Treatment response on D30 | |||||
CR | 13 | 68 | – | – | – |
NR | 6 | 32 | – | – | – |
Follow-up | |||||
CR group | 13 | ||||
allo-HCT | – | – | 11 | 10 | 1/1(same case) |
non-HCT | – | – | 2 | 0 | 2/1 |
NR group | 6 | ||||
allo-HCT | – | – | 3 | 1 | 2/1 |
non-HCT | – | – | 3 | 0 | 0/3 |